Cargando…
DUB3/KLF4 combats tumor growth and chemoresistance in hepatocellular carcinoma
This study aimed to investigate the role of deubiquitinating enzyme 3 (DUB3) in the regulation of Krüppel-like factor 4 (KLF4) expression in hepatocellular carcinoma (HCC). Gain- and loss-of-function assay, luciferase reporter assay, co-immunoprecipitation, and intracellular and extracellular deubiq...
Autores principales: | Jia, Xuebing, Li, Lei, Wang, Fan, Xue, Ying, Wu, Tongde, Jia, Qianqian, Li, Yunhui, Wu, Chenming, Chen, Yuping, Wu, Jinhuan, Su, Yang, Wang, Xinshu, Zhuang, Tao, Dong, Xiao, Ling, Jing, Yuan, Jian, Li, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983766/ https://www.ncbi.nlm.nih.gov/pubmed/35383144 http://dx.doi.org/10.1038/s41420-022-00988-5 |
Ejemplares similares
-
DDX17 promotes hepatocellular carcinoma progression via inhibiting Klf4 transcriptional activity
por: Xue, Ying, et al.
Publicado: (2019) -
The deubiquitinase USP9X promotes tumor cell survival and confers chemoresistance through YAP1 stabilization
por: Li, Lei, et al.
Publicado: (2018) -
Research Progress of DUB Enzyme in Hepatocellular Carcinoma
por: Zhao, Jie, et al.
Publicado: (2022) -
The Functions and Mechanisms of PR-DUB in Malignancy
por: Cao, Lei, et al.
Publicado: (2021) -
CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1
por: Liu, Tongzheng, et al.
Publicado: (2017)